Published date: 21 January 2025
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£9,867,000
Procurement reference
CF-2796900D0O000000rwimUAA
Published date
21 January 2025
Closing date
18 November 2024
Closing time
1pm
Contract start date
1 February 2025
Contract end date
31 May 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
More information
Attachments
-
- Document No. 09 - Participating Authorities - CM_TNS_24_5713.xls
- Document No. 09 - Participating Authorities - CM_TNS_24_5713
-
- Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5713.docx
- Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5713
-
- Transparency Documents - CM_TNS_24_5713_01.pdf
- Transparency Documents - CM_TNS_24_5713_01
-
- Parties Appointed to the Framework Agreement - CM-TNS-24-5713.docx
- Parties Appointed to the Framework Agreement - CM-TNS-24-5713
-
- FTS 2024S 000-031160 - CM-TNS-24-5713 - Opportunity Notice.pdf
- FTS 2024S 000-031160 - CM-TNS-24-5713 - Opportunity Notice
Award information
Awarded date
14 January 2025
Contract start date
1 February 2025
Contract end date
31 May 2026
Total value of contract
£9,867,000
This contract was awarded to 6 suppliers.
Sun Pharma UK Ltd
Address
6-9 The Square, Stockley Park,, Uxbridge, UB11 1FW
Reference
None
Supplier is SME?
No
Thornton and Ross Ltd
Address
Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, HD7 5QH
Reference
None
Supplier is SME?
No
Dr.Reddy's Laboratories (UK) Limited
Address
410, Cambridge Science Park Milton Rd, Milton,, Cambridge, CB4 0PE
Reference
None
Supplier is SME?
Yes
Zentiva Pharma UK Ltd
Address
12 New Fetter Lane,, London, EC4A 1JP
Reference
None
Supplier is SME?
No
Biocon
Address
6 Great Queen Street, Covent Garden,, London, United Kingdom,, WC2B 5AH
Reference
None
Supplier is SME?
No
Baxter Healthcare Ltd
Address
Caxton Way, Thetford,, Norfolk,, IP24 3SE
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Katie Noonan
Address
2nd Floor, Rutland House
Runcorn, Cheshire
WA7 2ES
GB
Share this notice
Closing: 18 November 2024, 1pm